Triastek’s T22 3D printed gastric retention drug receives FDA clearance
Chinese language drug 3D printing agency Triastek has introduced that its T22 3D printed gastric retention product has develop into the primary drug of its type to obtain Investigational New Drug (IND) clearance from the US Meals and Drug Administration (FDA). T22 has been filed beneath part 505(B)(2) of the FDA’s Federal Meals, Drug, and […]


